Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾ÀÇ Ä¡Çè·Ê

MUCOEPIDERMOID CARCINOMA OF THE PALATE

¼Ò¼Ó »ó¼¼Á¤º¸
ȲÀçÈ«/Jae Hong Hwang À̽¿±/¹Ú°ü¼ö/Á¤±âÈÆ/ÀüÀμº/À±±ÔÈ£/Seung Yeop Lee/Kwan Soo Park/Ki Hoon Jeong/In Seong Jeon/Kyu Ho Yoon

Abstract

¼­·Ð
Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾Àº Á¡¾×ºÐºñ¼¼Æ÷, À¯Ç¥ÇǼ¼Æ÷, Áß°£¼¼Æ÷µéÀÌ ´Ù¾çÇÑ ºÐÆ÷¸¦ ÀÌ·ç¸ç, Çdz¶ÀÌ
Çü¼ºµÇ¾î ÀÖÁö ¾ÊÀº Á¾¾çÀ¸·Î, ¸ðµç Á¡¾×Ç¥ÇǾç(mucoepidermoid) º´¼ÒµéÀº ¾ÏÁ¾À̸ç, ÀüÀÌ
ÇÑ´Ù. ±×·¯³ª, ³·Àº ¾Ç¼ºÀÇ Á¡¾×Ç¥ÇǾÏÀº ±¹¼ÒÀûÀ¸·Î ħ½ÀÇÏ¸ç »ó´ëÀûÀ¸·Î ³·Àº °ø°Ý¼ºÀ» Áö
´Ñ´Ù.
Ÿ¾×¼± µµ°ü°èÀÇ ¼Ò¿±°£ ¶Ç´Â ¼Ò¿±³»ºÎÀÇ reserve cell¿¡¼­ ±â½ÃÇϸç, È¥ÇÕÇ¥ÇÇ ¼¼Æ÷(mixed
epidermoid cell:keratin intermediate filament ÇÔÀ¯)¿Í Á¡¾×ºÐºñ ¼¼Æ÷(neral glycoproteins, »ê
¼ºÁ¡¾×¼Ò, ȲȭÁ¡¾×¼Ò ÇÔÀ¯)°¡ Á¸ÀçÇÑ´Ù.
ÀÌÇϼ±(60¡­90%)¿¡¼­ °¡Àå È£¹ßÇϸç, Ÿ¾×¼± ¾Ç¼º Á¾¾ç Áß °¡Àå ÈçÇϸç, ¾î¸°ÀÌ¿¡µµ °¡Àå
ÈçÇÑ ¾Ç¼º Á¾¾çÀÌ´Ù. Àüü Ÿ¾×¼±Á¾¾çÀÇ 6¡­9%¸¦ ÀÌÇϼ± ¾Ç¼º Á¾¾ç Áß 34%, ¾ÇÇϼ± ¾Ç¼º
Á¾¾çÁß 20%, ±¸°­³» ¾Ç¼º Á¾¾ç Áß 29%¸¦ Â÷ÁöÇÏ¸ç ¼ºÂ÷´Â ¾ø°í, Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾Àº ´ë·«
¸ðµç Ÿ¾×¼± ¾ÏÁ¾ÀÇ 6¡­8% ÇØ´çµÈ´Ù.
Patey µîÀº ¸ðµç ÀÌÇϼ± ¾ÏÁ¾ÀÇ 12%¿¡ ÇØ´çµÈ´Ù°í ÇÏ¿´°í, Eneroth´Â ¾ÇÇϼ± ¾ÏÁ¾À» ¿¬±¸
Çߴµ¥ ÀÌ Áß Á¡¾×À¯Ç¥ÇÇ ¾ÏÁ¾ÀÌ 6%¸¦ Â÷ÁöÇÑ´Ù°í ÇÏ¿´À¸¸ç, Luccioli´Â ¸ðµç ´ë, ¼ÒŸ¾×¼±
¾ÏÁ¾Áß 24%°¡ Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾À̶ó°í ÇÏ¿´´Ù. ¾Ç¼ºµµ¿¡ µû¶ó Àú±Þ, Áß±Þ, °í±Þ(low-grade,
intermediate-grade, high-grade malignancy)À¸·Î ±¸ºÐµÇ¸ç, Àú±Þ ¾Ç¼ºÇüÀÎ °æ¿ì¿¡´Â ¾ç¼ºÈ¥
ÇÕÁ¾°ú À¯»çÇÑ ¾ç»ó Áï ¹«Å뼺 ÆØâ°ú ºñ´ë¸¦ º¸À̳ª, ºÒ¿ÏÀüÇÏ°Ô ÇǸ·È­µÇ¾î ÀÖ°í, ±¸°­³»
º´¼Ò´Â Á¡¾×·ù¿Í À¯»çÇÏ¸ç ¶§¶§·Î Á¡¾×À¸·Îä¿öÁø ³¶À» Çü¼ºÇÏ¿© ¾×»óÀ» ³ªÅ¸³»±âµµ Çϸç,
±¸°³ º´¼Ò´Â Ä¡±Ù´Ü Ä¡ÁÖ³¶ ¶Ç´Â Ä¡ÁÖ³ó¾çÀ¸·Î ÀÓ»óÀû Áø´ÜÇÒ ¼ö ÀÖ´Ù. °í±Þ¾Ç¼ºÇüÀÎ °æ¿ì
¿¡´Â »¡¸® Áõ½ÄÇϸç Á¾Á¾ µ¿Åë°ú Á¡¸·ÀÇ ±Ë¾çÀ» µ¿¹ÝÇÏ°í, ÇǸ·À¸·Î µÑ·¯½Î¿© ÀÖÁö ¾Ê°í, ÁÖ
À§ Á¶Á÷À¸·Î Ĩ½ÀÇÏ¸ç ¿ø°ÝÀüÀÌÇÏ¸ç ´ëŸ¾×¼± º´¼Ò´Â ¾È¸é½Å°æ¸¶ºñ ¶Ç´Â Ÿ¾×¼± µµ°ü Æó¼â
ÀÇ Â¡Èĸ¦ ³ªÅ¸³»±âµµ ÇÑ´Ù. Á߱޾ǼºÇüÀÏ ¶§ ¿Ü°úÀû ÀýÁ¦¿Í ¹æ»ç¼± ¿ä¹ýÀ» º´ÇàÇϸç, °í±Þ
¾Ç¼ºÇüÀÏ ¶§ 5³âÀ̳» 60%¿¡¼­ ÀüÀÌÇϸç, 5³â »ýÁ¸À²ÀÌ 40% Á¤µµÀÌ´Ù.
º» ±³½Ç¿¡¼­´Â °æ±¸°³ºÎ¿¡ ¹ß»ýÇÑ Áß±ÞÀÇ Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾À» ÀýÁ¦ÇÏ°í ¹æ»ç¼±¿ä¹ý°ú º´Çà
ÇÏ¿© Ä¡·áÇÏ¿¡ ¾çÈ£ÇÑ °á°ú¸¦ ¾ò¾ú±â¿¡ ¹®Çå°íÂû°ú ÇÔ²² º¸°íÇϴ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
The mucoepidermoid carcinoma is classified as either well, moderately, or poorly
differentiated. The criteria used to classify the lesions are discussed, and pathologic
features are illustrated.
The most important factors in prognosis are :
1. degree of histologic differentiation, and 2. presence or abscence of tumor on the lines
of surgical excision.
Recurrences rates are correlated with histologic differentiation.
Stewart, Foote, and Becker in 1945 coined the term 'mucoepidermoid tumor' to describe
an unusual salivary neoplasm containing epidermoid and mucus-secreting cells which
was thought of arise in salivary gland ducts.
The treatment of the mucoepidermoid carcinoma is chiefly surgical, although recent
data have shown favorable responses to radiation therapy. Currently, surgery followed
by radiation treatment id recommended for intermediate grade and high-grade tumors ;
low-grade tumors can be managed by surgery alone.
Authors present a case of mucoepidermoid carcinoma managed with wide surgical
resection and postoperative irradiation and showing a good clinical result with review of
literatures.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed